86 related articles for article (PubMed ID: 2545843)
1. Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue.
Engelhard HH; Butler AB; Bauer KD
J Neurosurg; 1989 Aug; 71(2):224-32. PubMed ID: 2545843
[TBL] [Abstract][Full Text] [Related]
2. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
3. Limitations in the measurement of c-myc oncoprotein and other nuclear antigens by flow cytometry.
Lincoln ST; Bauer KD
Cytometry; 1989 Jul; 10(4):456-62. PubMed ID: 2670485
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry.
Engelhard HH; Krupka JL; Bauer KD
Cytometry; 1991; 12(1):68-76. PubMed ID: 1900228
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of glioblastoma cell differentiation.
Engelhard HH; Duncan HA; Dal Canto M
Neurosurgery; 1997 Oct; 41(4):886-96; discussion 896-7. PubMed ID: 9316051
[TBL] [Abstract][Full Text] [Related]
6. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J
Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683
[TBL] [Abstract][Full Text] [Related]
7. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
8. A quantitative analysis of modulations occurring in cellular c-myc protein content, %S phase and growth balance under growth-inhibitory conditions.
Engelhard HH
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):607-20. PubMed ID: 8220071
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukaemia during induced maturation with cytosine arabinoside and dimethylsulphoxide.
Dent GA; Ayscue LH; High KA; Leglise MC; Ross DW
Cell Tissue Kinet; 1989 Jan; 22(1):1-11. PubMed ID: 2676187
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
12. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
13. Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.
Khalid MH; Shibata S; Hiura T
J Neurosurg; 1999 May; 90(5):918-27. PubMed ID: 10223459
[TBL] [Abstract][Full Text] [Related]
14. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.
Kastan MB; Stone KD; Civin CI
Blood; 1989 Oct; 74(5):1517-24. PubMed ID: 2506946
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of cellular ras p21 oncogene product and DNA content by two-parameter flow cytometry.
Giordano M; Danova M; Riccardi A; Mazzini G
Anticancer Res; 1989; 9(3):799-803. PubMed ID: 2669621
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
Hendy-Ibbs P; Cox H; Evan GI; Watson JV
Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of c-myc oncogene product in human brain tumors].
Nakajima Y; Yoshimine T; Hayakawa T; Maruno M; Mushiroi T; Nakagawa H; Mogami H
No To Shinkei; 1989 Jun; 41(6):617-21. PubMed ID: 2679824
[TBL] [Abstract][Full Text] [Related]
18. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
Pääkkö P; Nuorva K; Kamel D; Soini Y
Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
[TBL] [Abstract][Full Text] [Related]
19. Development of a two color immunofluorescence stain and immunolocalization method for N-myc and c-myc oncoproteins with a newly generated mouse IgM anti N-myc antibody.
Gazitt Y; He YJ; Erdos GW; Chang L; Ashktorab H; Cohen RJ
J Immunol Methods; 1992 Apr; 148(1-2):159-69. PubMed ID: 1564326
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
